HTGmedical also received a grant of 160k EUR from Technologicka inkubace by Czechinvest, making the total amount of funding to 760k EUR.
The funding will enable HTG Medical to complete MDR certification, launch production, and scale the product to new markets. The company has already conducted pilot testing in IKEM and other Czech hospitals and is planning expansion into Slovakia, the Netherlands, and Spain in 2025.
“I was genuinely surprised that we ended up approving an investment in medical hardware requiring certification. We even shook hands on it just two days after I had declared that I would never invest in anything but pure B2B SaaS. Sometimes, you just have to change your mind, especially with a team this capable and a mission this meaningful,” says Jan Sláma from Jinej Fond.
“HTG Medical is exactly the type of innovation I love – not just theoretical ideas, but a concrete solution that saves nurses hours of work every day. When hospitals improve, I want to be part of it,” adds Miroslav Uďan, one of the investors.
Founded in 2021, the startup addresses the needs of medical professionals with HW and SW solutions that aim to simply and effectively solve the problem at hand without forcing any new systems and workflows onto already overcomplicated hospitals and medical centers.
The journey of three young co-founders Max Klimeš, Tobias Vybiral and Kristof Saman started at a hackathon in 2019. The collective purpose was to use technology to help save lives and unburden nurses. That idea came during a hackathon IKEM (Institute for Clinical and Experimental Medicine).
The company participated in the Caelestinus and ČSOB Start-IT accelerators, received support from CzechInvest’s Tech4Life incubation program, and is now preparing for certification and full market launch.
“Our long-term vision extends far beyond hospitals. We believe that automated vital sign monitoring will play a crucial role in the future of healthcare—whether in intensive care units, home monitoring, or even inside astronaut spacesuits on Mars,” adds Vybíral.
The next step in a company future is to build a HTG Urogram, an innovative device that automates urine output monitoring and sends real-time data to hospital systems. This small “box” can take measurements every five minutes, reduce errors, and save nurses hours of manual work—a task still done manually every hour with pen and paper.
The investment was done together by Lumus Collective, together with Jinej fond by Jiri Hlavenka and Jan Slama, then Miroslav Uďan, investment fund 10x with Matěj Turek, CFA and Dendis Capital by Miloš Dendis.
“Nurses in ICUs are overworked and understaffed, and the situation in many European hospitals will only worsen. Our goal is not to overhaul the entire system, but to eliminate specific repetitive tasks that can be easily automated, freeing up an hour of nurses’ time daily for actual patient care,” says Tobiáš Vybíral, Co-founder and CEO of HTG Medical.
